Key result
Cadmium exposure induced dramatic endoplasmic reticulum stress and impaired energy homoeostasis in cultured cardiomyocytes, potentially by inhibiting the AKT/mTOR pathway.
Cadmium toxicity induces ER stress and impairs energy homeostasis in cardiomyocytes via the AKT/mTOR pathway, providing mechanistic insights into cadmium-related cardiovascular diseases.
Should not change clinical practice; hypothesis-generating for cadmium-related cardiomyocyte injury via AKT/mTOR in humans.
Cadmium, a highly toxic environmental pollutant, is reported to induce toxicity and apoptosis in multiple organs and cells, all possibly contributing to apoptosis in certain pathophysiologic situations. Previous studies have described that cadmium toxicity induces biochemical and physiological changes in the heart and finally leads to cardiac dysfunctions, such as decreasing contractile tension, rate of tension development, heart rate, coronary flow rate and atrioventricular node conductivity. Although many progresses have been made, the mechanism responsible for cadmium-induced cellular alternations and cardiac toxicity is still not fully understood. In the present study, we demonstrated that cadmium toxicity induced dramatic endoplasmic reticulum (ER) stress and impaired energy homoeostasis in cultured cardiomyocytes. Moreover, cadmium toxicity may inhibit protein kinase B (AKT)/mTOR (mammalian target of rapamycin) pathway to reduce energy productions, by either disrupting the glucose metabolism or inhibiting mitochondrial respiratory gene expressions. Our work will help to reveal a novel mechanism to clarify the role of cadmium toxicity to cardiomyocytes and provide new possibilities for the treatment of cardiovascular diseases related to cadmium toxicity.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2015) studied Cadmium toxicity. Cadmium was evaluated on Endoplasmic reticulum (ER) stress and energy homoeostasis. Cadmium exposure induced dramatic endoplasmic reticulum stress and impaired energy homoeostasis in cultured cardiomyocytes, potentially by inhibiting the AKT/mTOR pathway.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: